| Dr Daniel Gene Bintz, OD | |
|
920 N Main St, Elk City, OK 73644-2829 | |
| (580) 243-1121 | |
| (580) 243-1145 |
| Full Name | Dr Daniel Gene Bintz |
|---|---|
| Gender | Male |
| Speciality | Optometry |
| Experience | 40 Years |
| Location | 920 N Main St, Elk City, Oklahoma |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1033203765 | NPI | - | NPPES |
| 100764360A | Medicaid | OK |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | 1071 (Oklahoma) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Doctors Bintz And Ellis | 1951486042 | 2 |
News Archive
VBL Therapeutics, a clinical stage biotechnology company committed to the development of novel treatments for immune-inflammatory diseases and cancer, today announced that a Phase 2 sub-study of VB-201 in moderate to severe psoriasis patients with cardiovascular risk has successfully achieved its primary endpoint demonstrating a statistically significant reduction in vascular inflammation associated with atherosclerotic lesions as measured by PET-CT imaging.
Preschoolers' fine and gross motor skill development is indicative of later performance on two key measures of kindergarten readiness, according to a study published today by researchers from Oregon State University.
Researchers from the Department of Infection and Immunity of the Luxembourg Institute of Health (LIH) brought forward the potential of high doses of a specific adjuvant molecule, namely CpG oligonucleotide, in successfully modulating the immune system's allergic response to the main cat allergen Fel d 1, thereby inducing a tolerance-promoting reaction and reverting the main hallmarks of cat allergy.
Marinomed Biotechnologie GmbH, a company focused on the development of innovative therapies for respiratory diseases, announced today that it has signed a licensing agreement with the international pharmaceutical company Boehringer Ingelheim. The deal will aim to further extend marketing of Marinomed's anti-viral nasal spray for the treatment of the Common Cold to all of Europe (except Austria and UK), Russia and CIS, South America, parts of Asia and Australia.
› Verified 2 days ago
| Provider Name | Doctors Bintz & Ellis |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1831383793 PECOS PAC ID: 1951486042 Enrollment ID: O20080313000414 |
News Archive
VBL Therapeutics, a clinical stage biotechnology company committed to the development of novel treatments for immune-inflammatory diseases and cancer, today announced that a Phase 2 sub-study of VB-201 in moderate to severe psoriasis patients with cardiovascular risk has successfully achieved its primary endpoint demonstrating a statistically significant reduction in vascular inflammation associated with atherosclerotic lesions as measured by PET-CT imaging.
Preschoolers' fine and gross motor skill development is indicative of later performance on two key measures of kindergarten readiness, according to a study published today by researchers from Oregon State University.
Researchers from the Department of Infection and Immunity of the Luxembourg Institute of Health (LIH) brought forward the potential of high doses of a specific adjuvant molecule, namely CpG oligonucleotide, in successfully modulating the immune system's allergic response to the main cat allergen Fel d 1, thereby inducing a tolerance-promoting reaction and reverting the main hallmarks of cat allergy.
Marinomed Biotechnologie GmbH, a company focused on the development of innovative therapies for respiratory diseases, announced today that it has signed a licensing agreement with the international pharmaceutical company Boehringer Ingelheim. The deal will aim to further extend marketing of Marinomed's anti-viral nasal spray for the treatment of the Common Cold to all of Europe (except Austria and UK), Russia and CIS, South America, parts of Asia and Australia.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Daniel Gene Bintz, OD Po Box 9, Elk City, OK 73648-0009 Ph: (580) 243-1121 | Dr Daniel Gene Bintz, OD 920 N Main St, Elk City, OK 73644-2829 Ph: (580) 243-1121 |
News Archive
VBL Therapeutics, a clinical stage biotechnology company committed to the development of novel treatments for immune-inflammatory diseases and cancer, today announced that a Phase 2 sub-study of VB-201 in moderate to severe psoriasis patients with cardiovascular risk has successfully achieved its primary endpoint demonstrating a statistically significant reduction in vascular inflammation associated with atherosclerotic lesions as measured by PET-CT imaging.
Preschoolers' fine and gross motor skill development is indicative of later performance on two key measures of kindergarten readiness, according to a study published today by researchers from Oregon State University.
Researchers from the Department of Infection and Immunity of the Luxembourg Institute of Health (LIH) brought forward the potential of high doses of a specific adjuvant molecule, namely CpG oligonucleotide, in successfully modulating the immune system's allergic response to the main cat allergen Fel d 1, thereby inducing a tolerance-promoting reaction and reverting the main hallmarks of cat allergy.
Marinomed Biotechnologie GmbH, a company focused on the development of innovative therapies for respiratory diseases, announced today that it has signed a licensing agreement with the international pharmaceutical company Boehringer Ingelheim. The deal will aim to further extend marketing of Marinomed's anti-viral nasal spray for the treatment of the Common Cold to all of Europe (except Austria and UK), Russia and CIS, South America, parts of Asia and Australia.
› Verified 2 days ago
Robin Lynn Smith-trotter, Optometrist Medicare: Accepting Medicare Assignments Practice Location: 1020 N Main St, Elk City, OK 73644 Phone: 580-225-1555 Fax: 580-225-1558 | |
Jessica Greene, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 800 N Main St, Elk City, OK 73644 Phone: 580-225-1980 | |
Dr. Nok Ken Wan, OD Optometrist Medicare: Not Enrolled in Medicare Practice Location: 1710 W 3rd St, Elk City, OK 73644 Phone: 580-225-1555 | |
Dr. Gary L. Ford & Dr. John D. Edwards Optometrist Medicare: Not Enrolled in Medicare Practice Location: 101 N Randall Ave, Elk City, OK 73644 Phone: 580-225-1980 Fax: 580-225-8648 | |
Drs. Ford And Edwards, Pllc Optometrist Medicare: Not Enrolled in Medicare Practice Location: 101 N Randall Ave, Elk City, OK 73644 Phone: 580-225-1980 Fax: 580-225-8648 | |
Eyecare Of Western Oklahoma Pc Optometrist Medicare: Medicare Enrolled Practice Location: 800 N Main St, Elk City, OK 73644 Phone: 580-225-1978 Fax: 580-225-8648 |